Synthesis and preliminary evaluation of (S)-(2-[18F]fluoro-4,5-dihydroxyphenyl)-2-methyl l-alanine, (S)-[18F]-FMEDOPA, a potentially improved imaging agent for the presynaptic dopaminergic nervous system
- 31 October 1996
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 23 (7) , 857-865
- https://doi.org/10.1016/s0969-8051(96)00056-x
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Functional imaging in relation to parkinsonian syndromesJournal of the Neurological Sciences, 1993
- Presynaptic and postsynaptic striatal dopaminergic function in neuroacanthocytosis: A positron emission tomographic studyAnnals of Neurology, 1991
- Positron emission tomography suggests that the rate of progression of idiopathic parkinsonism is slowAnnals of Neurology, 1991
- Differing patterns of striatal 18F‐dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsyAnnals of Neurology, 1990
- Synthesis of O‐ and M‐tyrosine analogs as potential tracers for CNS dopamineJournal of Labelled Compounds and Radiopharmaceuticals, 1989
- A positron emitting inhibitor of aromatic L‐aminoacid decarboxylase: α‐fluoromethyl‐6‐[F‐18]fluoro‐L‐DOPAJournal of Labelled Compounds and Radiopharmaceuticals, 1989
- In Vivo Assessment of Neurotransmitter Biochemistry in HumansAnnual Review of Pharmacology and Toxicology, 1988
- Altered metabolism of [18F]-6-fluorodopa in the hooded rat following inhibition of catechol-O-methyltransferase with U-0521Biochemical Pharmacology, 1987
- Stereochemical course in vivo of alpha-methyldopa decarboxylation in rat brainsBiochemical Pharmacology, 1977
- The metabolism of14C-labelled α-methyldopa in normal and hypertensive human subjectsBiochemical Journal, 1972